Brachytherapy quality assurance in the PORTEC-4a trial for high-intermediate risk endometrial cancer

B. Wortman; E. Astreinidou; M. Laman; L. Lutgens; E. Van der Steen-Banasik; A. Slot; H. Westerveld; K. De Winter; H. Van den Berg; M. Bloemers; T. Stam; J. Mens; L. Zwanenburg; S. Bijmolt; I. Juergenliemk-Schulz; A. Snyers; C. Creutzberg; R. Nout

doi:10.1016/S0167-8140(19)30814-X

Brachytherapy quality assurance in the PORTEC-4a trial for high-intermediate risk endometrial cancer

B. Wortman, E. Astreinidou, M. Laman, L. Lutgens, E. Van der Steen-Banasik, A. Slot, H. Westerveld, K. De Winter, H. Van den Berg, M. Bloemers, T. Stam, J. Mens, L. Zwanenburg, S. Bijmolt, I. Juergenliemk-Schulz, A. Snyers, C. Creutzberg, R. Nout

Targeted Gynaecologic Oncology (TARGON)

Onderzoeksoutput › Academic

66 Downloads (Pure)

Originele taal-2	English
Pagina's (van-tot)	S198-S199
Aantal pagina's	2
Tijdschrift	Radiotherapy and Oncology
Volume	133
DOI's	https://doi.org/10.1016/S0167-8140(19)30814-X
Status	Published - apr.-2019
Evenement	38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) - Milan, Italy Duur: 26-apr.-2019 → 30-apr.-2019

Toegang tot document

10.1016/S0167-8140(19)30814-XLicentie: CC BY-NC-ND

OC-0394 Brachytherapy quality assurance in the PORTEC-4a trial for high-intermediate risk endometrial cancerFinal publisher's version, 1,78 MBLicentie: CC BY-NC-ND

Handle.net

Permanente koppeling

Citeer dit

Wortman, B., Astreinidou, E., Laman, M., Lutgens, L., Van der Steen-Banasik, E., Slot, A., Westerveld, H., De Winter, K., Van den Berg, H., Bloemers, M., Stam, T., Mens, J., Zwanenburg, L., Bijmolt, S., Juergenliemk-Schulz, I., Snyers, A., Creutzberg, C., & Nout, R. (2019). Brachytherapy quality assurance in the PORTEC-4a trial for high-intermediate risk endometrial cancer. Radiotherapy and Oncology, 133, S198-S199. https://doi.org/10.1016/S0167-8140(19)30814-X

@article{552b5f525e8e4a00a9d3048783e8e4e8,

title = "Brachytherapy quality assurance in the PORTEC-4a trial for high-intermediate risk endometrial cancer",

author = "B. Wortman and E. Astreinidou and M. Laman and L. Lutgens and {Van der Steen-Banasik}, E. and A. Slot and H. Westerveld and {De Winter}, K. and {Van den Berg}, H. and M. Bloemers and T. Stam and J. Mens and L. Zwanenburg and S. Bijmolt and I. Juergenliemk-Schulz and A. Snyers and C. Creutzberg and R. Nout",

year = "2019",

month = apr,

doi = "10.1016/S0167-8140(19)30814-X",

language = "English",

volume = "133",

pages = "S198--S199",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "ELSEVIER IRELAND LTD",

note = "38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO) ; Conference date: 26-04-2019 Through 30-04-2019",

}

Wortman, B, Astreinidou, E, Laman, M, Lutgens, L, Van der Steen-Banasik, E, Slot, A, Westerveld, H, De Winter, K, Van den Berg, H, Bloemers, M, Stam, T, Mens, J, Zwanenburg, L, Bijmolt, S, Juergenliemk-Schulz, I, Snyers, A, Creutzberg, C & Nout, R 2019, 'Brachytherapy quality assurance in the PORTEC-4a trial for high-intermediate risk endometrial cancer', Radiotherapy and Oncology, vol. 133, blz. S198-S199. https://doi.org/10.1016/S0167-8140(19)30814-X

TY - JOUR

T1 - Brachytherapy quality assurance in the PORTEC-4a trial for high-intermediate risk endometrial cancer

AU - Wortman, B.

AU - Astreinidou, E.

AU - Laman, M.

AU - Lutgens, L.

AU - Van der Steen-Banasik, E.

AU - Slot, A.

AU - Westerveld, H.

AU - De Winter, K.

AU - Van den Berg, H.

AU - Bloemers, M.

AU - Stam, T.

AU - Mens, J.

AU - Zwanenburg, L.

AU - Bijmolt, S.

AU - Juergenliemk-Schulz, I.

AU - Snyers, A.

AU - Creutzberg, C.

AU - Nout, R.

PY - 2019/4

Y1 - 2019/4

U2 - 10.1016/S0167-8140(19)30814-X

DO - 10.1016/S0167-8140(19)30814-X

M3 - Meeting Abstract

SN - 0167-8140

VL - 133

SP - S198-S199

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

T2 - 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO)

Y2 - 26 April 2019 through 30 April 2019

ER -